Prognostic significance of serum CA 19-9 response and dynamics in patients with intrahepatic cholangiocarcinoma undergoing surgical resection

被引:1
|
作者
DiPeri, Timothy P. [1 ]
Newhook, Timothy E. [1 ]
Tzeng, Ching-Wei D. [1 ]
Chun, Yun Shin [1 ]
Lee, Sunyoung S. [1 ]
Javle, Milind M. [1 ]
Vauthey, Jean-Nicolas [1 ]
Cao, Hop Sanderson Tran [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1200/JCO.2022.40.4_suppl.479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
479
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Impact of perioperative serum CA 19-9 levels on survival outcomes in patients with intrahepatic cholangiocarcinoma
    Ryu, J.
    Lee, S.
    Kim, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S99 - S100
  • [2] Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
    Kim, Si-Young
    Lee, Hee-Seung
    Bang, Seung-Min
    Han, Dai-Hoon
    Hwang, Ho-Kyoung
    Choi, Gi-Hong
    Chung, Moon-Jae
    Kim, Seung-Up
    CANCERS, 2021, 13 (08)
  • [3] CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
    Sven H. Loosen
    Christoph Roderburg
    Katja L. Kauertz
    Alexander Koch
    Mihael Vucur
    Anne T. Schneider
    Marcel Binnebösel
    Tom F. Ulmer
    Georg Lurje
    Wenzel Schoening
    Frank Tacke
    Christian Trautwein
    Thomas Longerich
    Cornelis H. Dejong
    Ulf P. Neumann
    Tom Luedde
    Scientific Reports, 7
  • [4] CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
    Loosen, Sven H.
    Roderburg, Christoph
    Kauertz, Katja L.
    Koch, Alexander
    Vucur, Mihael
    Schneider, Anne T.
    Binneboesel, Marcel
    Ulmer, Tom F.
    Lurje, Georg
    Schoening, Wenzel
    Tacke, Frank
    Trautwein, Christian
    Longerich, Thomas
    Dejong, Cornelis H.
    Neumann, Ulf P.
    Luedde, Tom
    SCIENTIFIC REPORTS, 2017, 7
  • [5] The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma
    Jaklitsch, Manuel
    Petrowsky, Henrik
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [6] Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma
    Tangkijvanich, P
    Thong-ngam, D
    Theamboonlers, A
    Hanvivatvong, O
    Kullavanijaya, P
    Poovorawan, Y
    HEPATO-GASTROENTEROLOGY, 2004, 51 (55) : 15 - 19
  • [7] Diagnostic accuracy of serum Ca 19-9 in predicting malignancy in patients undergoing pancreatic resection.
    Bekaii-Saab, TS
    Cowgill, SM
    Burak, WE
    Melvin, WS
    Ellison, EC
    Muscarella, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 365S - 365S
  • [8] Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection
    van Oosten, A. Floortje
    Groot, Vincent P.
    Dorland, Galina
    Burkhart, R. A.
    Wolfgang, Christopher L.
    van Santvoort, Hjalmar C.
    He, Jin
    Molenaar, I. Quintus
    Daamen, Lois A.
    ANNALS OF SURGERY, 2024, 279 (03) : 493 - 500
  • [9] Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9
    Lundin, J
    Roberts, PJ
    Kuusela, P
    Haglund, C
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2181 - 2186
  • [10] Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis
    Liu S.-L.
    Song Z.-F.
    Hu Q.-G.
    Shan D.
    Hu S.-B.
    Li J.
    Zheng Q.-C.
    Frontiers of Medicine in China, 2010, 4 (4): : 457 - 462